Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia-Reference-Cited by-同舟云学术

Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia

Published:2011-09 Issue:1 Volume:52 Page:17-22
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Amendola Alessandra,Bloisi Maria,Marsella Patrizia,Sabatini Rosella,Bibbò Angela,Angeletti Claudio,Capobianchi Maria Rosaria

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference35 articles.

1. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia;Wong;Science,1997

2. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy;Dornadula;JAMA,1999

3. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy;Natarajan;Lancet,1999

4. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy;Palmer;PNAS,2008

5. Evidence of persistent low-level of viremia in long term HAART-suppressed HIV-infected patients;Hatano;AIDS,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered T‐cell subset distribution in the viral reservoir in HIV‐1‐infected individuals with extremely low proviral DNA (LoViReTs);Journal of Internal Medicine;2022-03-28

2. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy;mBio;2021-12-21

3. Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1;Science Translational Medicine;2020-05-06

4. Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure;Scientific Reports;2020-02-05

5. Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab;Journal of Clinical Medicine;2019-12-01